Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARICO: OpCT-001 in Primary Photoreceptor Disease
NCT06789445Phase 2Recruiting
- Sponsor
- BlueRock Therapeutics
- Start
- Mar 2025
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
A Phase 2 trial of opct-001 in primary photoreceptor disease, sponsored by BlueRock Therapeutics. Started Mar 2025; status: recruiting.
02
Drugs
opct-001
03
Conditions
primary photoreceptor disease
Beyond the preview
Go deeper on NCT06789445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789445.